Skip to main content

Latest News

03/12/2019
New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for four new medicines, cefepime dihydrochloride monohydrate (Renapime®), diamorphine hydrochloride (Ayendi®), dupilumab (Dupixent®) and melatonin (Slenyto®).

13/12/2019
New medicines advice for NHS Wales

Welsh Government has approved new advice from the All Wales Medicines Strategy Group (AWMSG) for two medicines, fampridine (Fampyra®) and glycerol phenylbutyrate (Ravicti®). 

20/12/2019
Presentation at 5th Annual Welsh Rare Disease Patient Network Meeting

The AWMSG process for appraising medicines used to treat rare conditions was outlined and the results from a review of the process were presented.